We expect some competition in the ODS segment in 2Q25 although this should be offset by the continuous strong growth in the fintech segment. With M&A sentiment easing, we believe that further growth in adjusted EBITDA in 2H25 will serve as a catalyst to monitor (more colors during the 2Q25 analyst meeting). We maintain BUY on GOTO with a lower target price of Rp78. We use the SOTP method, applying EV/Sales multiples to each segment (ODS, fin-tech, e-commerce) — at levels similar to regional peer...
GREATER CHINA Strategy Market Strategy: 2H25: A big beautiful deal? INDONESIA Update GoTo Gojek Tokopedia (GOTO IJ/BUY/Rp59/Target: Rp78): EBITDA resilience back in focus as M&A noise fades. MALAYSIA Sector REITs: We maintain MARKET WEIGHT as the positives appear largely priced into current share prices, with limited near-term upside potential. Top picks: PREIT and CLMT. SINGAPORE Update CapitaLand Integrated Commercial Trust (CICT SP/BUY/S$2.15/Target: S$2.42): Organic growth from AEIs and t...
INDONESIA Strategy Alpha Picks: Outperformance In Apr 25 Remove ICBP, EXCL, and MIKA; add BBTN and GOTO. MALAYSIA Sector Property Amid tariff overhang concerns, we favour companies with clear earnings visibility, solid exposure to affordable housing, and clear re-rating catalysts. Maintain OVERWEIGHT. Update Axiata (AXIATA MK/BUY/RM2.09/Target: RM2.50) ...
What’s New: GoTo reiterated its adjusted EBITDA guidance in the range of IDR1.4trn to IDR1.6trn in FY25. ODS GTV and FinTech consumer lending loans outstanding outlook also remain intact despite macro and geopolitical uncertainties. We maintain our PT at IDR80. Analysts: Jin Yoon
What’s New: GoTo guided adjusted EBITDA in the range of IDR1.4trn to IDR1.6trn in FY25 partly driven by margin improvement in both ODS and FinTech. ODS GTV could grow low-to-mid teens YoY, while FinTech consumer lending loans outstanding could reach IDR8trn in 2025. We up our PT from IDR70 to IDR80 on improved outlook. Our updated PT of IDR80 implies a 4.1x FY25E EV/Revs (net). We maintain our NEUTRAL rating. Analysts: Jin Yoon
Donald Trump announced a 25% tariff on imports from Mexico and Canada. Imports of oil from Canada into the US are subject to a 10% tariff, in addition to an extra 10% tariff on imports from the US, Canada retaliated by imposing a 25% tariff on imports from the US, including beverages, cosmetics and paper products worth US$20b. Mexico and China are also expected to retaliate. The biggest risk is the potential underperformance of the JCI. Our top picks are ASII, BMRI, BBNI, BBTN, CMRY, KLBF, SIDO,...
Strategy: Trade War Begins: Our top picks are ASII, BMRI, BBNI, BBTN, CMRY, KLBF, SIDO, CTRA, ACES and GOTO. We have an end-25 target of 8,200 for the JCI. TRADERS’ CORNER Ciputra Development (CTRA IJ): Technical BUY Indo Tambangraya Megah (ITMG IJ): Technical BUY
The JCI delivered a 3.7% decline in 2024, underperforming the MSASJ after two previous years of outperformance. IDXENER was the top performing sector in the JCI with a 31.9% return. IDXFIN dropped 6.2% in 2024 with big banks delivering negative returns. Gains of over 100% have been observed in MLPT, SRAJ, JSPT, PTRO, PANI, CLEO and BRMS. The worst performers are SMGR, UNVR, MDKA, GGRM, TOWR, TLKM and HMSP. For 2025, our top picks are ASII, BMRI, BBNI, BRIS, CMRY, KLBF, SMRA, ACES and GOTO.
Strategy: 2024 JCI Return Analysis: Our top picks are ASII, BMRI, BBNI, BRIS, CMRY, KLBF, SMRA, ACES and GOTO. We have an end-25 target of 8,200 for the JCI. TRADERS’ CORNER Telkom Indonesia (TLKM IJ): Technical BUY Trimegah Bangun Persada (NCKL IJ): Technical BUY
The key takeaways from our regional KL conference are: a) most investors agree that Prabowo’s programmes are positive for Indonesia; b) investors are concerned about the widening budget deficit; c) foreign investors are pleased that local fund managers are buying; d) there is interest in syariah banks, particularly BRIS; and e) investors are inquiring about ACES vs Mr DIY Indonesia. Our top picks are ASII, BMRI, BBNI, BBTN, BRIS, CMRY, KLBF, SMRA, ACES and GOTO.
Strategy: Key Takeaways From Regional Strategy Conference: Our top picks are ASII, BMRI, BBNI, BBTN, BRIS, CMRY, KLBF, SMRA, ACES and GOTO. We have an end-25 target of 8,200 for the JCI. TRADERS’ CORNER PP Persero (PTPP IJ): Technical BUY Bukalapak.com (BUKA IJ): Technical BUY
Trump 2.0 is unlikely to deter Indonesia’s exports to the US as Indonesia should be able to maintain its cost competitiveness. Interest rates are likely to be reduced by 100bp in 2025 and our economist continues to foresee a stronger rupiah. For 2025, investors should focus on the beneficiaries of domestic policies, such as the automobile, banking, consumer, property and technology sectors. Our top picks are BBCA, BBNI, BMRI, BBTN, ASII, SMRA, CTRA, GOTO, CMRY, ACES, SIDO and KLBF.
Strategy: Focus On Beneficiaries Of Domestic Policies: Our top picks are BBCA, BBNI, BMRI, BBTN, ASII, SMRA, CTRA, GOTO, CMRY, ACES, SIDO and KLBF. We have an end-25 target of 8,200 for the JCI. TRADERS’ CORNER Mitra Keluarga Karyasehat (MIKA IJ): Technical BUY Bank Mandiri (BMRI IJ): Technical BUY
Trump 2.0 is unlikely to deter Indonesia’s exports to the US as Indonesia should be able to maintain its cost competitiveness. Interest rates are likely to be reduced by 100bp in 2025 and our economist continues to foresee a stronger rupiah. For 2025, investors should focus on the beneficiaries of domestic policies, such as the automobile, banking, consumer, property and technology sectors. Our top picks are BBCA, BBNI, BMRI, BBTN, ASII, SMRA, CTRA, GOTO, CMRY, ACES, SIDO and KLBF. We have an en...
GOTO guides for its ODS adjusted EBITDA margin to expand 25bp qoq to 1.2% in 2025, or Rp1t. Loan book could grow 20% qoq to Rp5t-5.5t in Dec 24 and increase further to Rp8.6t by Dec 25. 2025 adjusted fintech EBITDA could reach Rp200b by 2025. The losses from its e-commerce segment remain unpredictable as TikTok has spent Rp10t on Tokopedia in the past six months. Thus, GOTO could still record a net loss in 2025. With improvements in GOTO’s operations, we maintain BUY with a target price of Rp85.
GREATER CHINA Economics Economic Activity Mainly stable except for weakness in real estate. Results Alibaba Group (9988 HK/BUY/HK$87.20/Target: HK$130.00) 2QFY25: Seeking high quality growth and gradual monetisation. CSPC Pharmaceutical Group (1093 HK/HOLD/HK$5.13/Target: HK$5.50) 9M24: Disappointing results; targets positive revenue growth in 2025. JD Logistics, Inc (2618 HK/BUY/HK$14.16/Target: HK$22...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.